Biocompatibles is a leader in advanced biomedical polymers for medical devices and drug delivery. The Company is focused on developing products that will improve patient outcomes in the treatment of cardiovascular disease, cancer and benign tumours.
At the heart of Biocompatibles' strength and success are two flexible and versatile polymer technologies and the talented professionals who have developed these over the years. Biocompatibles employs 40+ professionals in research and development, 14 of whom have PhDs.
Biocompatibles’ in-licensed N-fil technology is utilised in the Bead Block embolisation device, the drug eluting bead and the DC Bead programmes. Biocompatibles' polymer drug delivery expertise is now showcased on the Dexamet stent, one of just three drug-eluting stents commercially available in Europe. The Company's intellectual property portfolio includes over 200 patents and patent applications worldwide.
Through past product filings the Company has established master files for its proprietary PC Technology™ with the FDA in the United States.
PC Technology is backed by an accumulated 210 years of staff experience and more than 100 published papers. A variety of healthcare products containing PC Technology are now sold throughout the world.
| Contact Details: |
| Farnham Business Park Weydon Lane |
| Farnham |
| Surrey |
| GU9 8QL |
| United Kingdom |
| Tel: | 44 (0)1252 732 732 |
| Fax: | 44 (0)1252 732 777 |
| Email: | sari.evetts@biocompatibles.com |
| WWW: | www.biocompatibles.com/
|
|
Loading...
|
Recent Publications by Biocompatibles UK Ltd: |  |
DC Bead: a major development in the toolbox for the interventional oncologist.
The DC Bead is fast becoming the product of choice for use in the... | 16th September, 2009
| Biocompatibles UK Ltd, Farnham Business Park, Weydon Lane, Farnham,
| Expert Rev Med Devices. 2009 Jul;6(4):389-400.
DOI Direct Link |
Poly(2-methacryloyloxyethyl phosphorylcholine) for protein conjugation.
The water-soluble, biocompatible polymer poly(2-methacryloyloxyethyl... | 31st March, 2009
| Biocompatibles UK Ltd, Weydon Lane, Farnham, Surrey, United Kingdom.
| Bioconjug Chem. 2008 Nov 19;19(11):2144-55.
DOI Direct Link |
Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation.
DC Bead is a sulfonate-modified, PVA-based microspherical embolisation... | 13th November, 2008
| Drug Delivery Division, Biocompatibles UK Ltd, Farnham Business Park,
| J Mater Sci Mater Med. 2008 Feb;19(2):767-75. Epub 2007 Jul 25.
DOI Direct Link |
The interface of medical devices and pharmaceuticals: Part I.
This two-part article considers the complexities of developing and... | 30th August, 2008
| Biocompatibles
| Med Device Technol. 2008 Mar-Apr;19(2):42, 44-5.
|
The interface of medical devices and pharmaceuticals: Part II.
The technical challenges of developing combination products were addressed... | 23rd August, 2008
| Biocompatibles
| Med Device Technol. 2008 May-Jun;19(3):38-43.
|
→View more Biocompatibles UK Ltd research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 341 times since April 2007, the link to the organisation's website has been followed 48 times
Search for more companies in Farnham
Search for more companies in Surrey
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Biocompatibles UK Ltd
